
Sign up to save your podcasts
Or


This week on Lunch Money, Brooke Roberts (Sharesies' co-founder) and Alice Rountree (Sharesies' Financial Analyst) chat to Brian Ward, CEO of ASX-listed company Aroa Biosurgery—a soft-tissue regeneration company that develops, manufactures and distributes medical and surgical products. Brian takes us through Aroa's business model, and reflects on Aroa's journey to becoming an ASX-listed company.
See omnystudio.com/listener for privacy information.
By Sharesies5
33 ratings
This week on Lunch Money, Brooke Roberts (Sharesies' co-founder) and Alice Rountree (Sharesies' Financial Analyst) chat to Brian Ward, CEO of ASX-listed company Aroa Biosurgery—a soft-tissue regeneration company that develops, manufactures and distributes medical and surgical products. Brian takes us through Aroa's business model, and reflects on Aroa's journey to becoming an ASX-listed company.
See omnystudio.com/listener for privacy information.

23 Listeners

97 Listeners

313 Listeners

10 Listeners

24 Listeners

25 Listeners

91 Listeners

21 Listeners

288 Listeners

11 Listeners

16 Listeners

18 Listeners

68 Listeners

8 Listeners

15 Listeners